Skin Autofluorescence, as Marker of Accumulation of Advanced Glycation Endproducts and of Cumulative Metabolic Stress, Is Not Increased in Patients with Systemic Sclerosis
Objective. To investigate whether advanced glycation endproducts (AGEs) in the skin are increased in patients with systemic sclerosis (SSc) and are related to the presence of disease-related and traditional cardiovascular risk factors. Methods. Skin autofluorescence, as a measure for the accumulatio...
Main Authors: | M. E. Hettema, H. Bootsma, R. Graaff, R. de Vries, C. G. M. Kallenberg, A. J. Smit |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | International Journal of Rheumatology |
Online Access: | http://dx.doi.org/10.1155/2011/417813 |
Similar Items
-
Is skin autofluorescence (SAF) representative of dermal advanced glycation endproducts (AGEs) in dark skin? A pilot study
by: Isabella M. Atzeni, et al.
Published: (2020-11-01) -
Methylglyoxal-Derived Advanced Glycation Endproducts Accumulate in Multiple Sclerosis Lesions
by: Suzan Wetzels, et al.
Published: (2019-04-01) -
The effect of advanced glycation endproduct accumulation on bone
by: Van Vliet, Miranda
Published: (2017) -
The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes
by: Hillebrands Jan-Luuk, et al.
Published: (2008-10-01) -
The Association Between Anemia and Skin Autofluorescence, a Marker for Advanced Glycation End Product Accumulation
by: Hanneke J.C.M. Wouters, et al.
Published: (2020-12-01)